3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Glioblastoma
6
Rectal Neoplasms
5
Oropharyngeal Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Burkitt Lymphoma
4
Astrocytoma
4
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Glioma
3
Carcinoma, Squamous Cell
3
Adenocarcinoma of Lung
3
Rhabdomyosarcoma
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma, Follicular
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Esophageal Neoplasms
2
Carcinoma
2
Breast Carcinoma In Situ
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Interventions
pembrolizumab
9
Cetuximab
5
Surveys and Questionnaires
4
Cisplatin
4
dostarlimab
2
abemaciclib
2
Standard of Care
2
Docetaxel
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
tipifarnib
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
olaparib
1
nimotuzumab
1
monalizumab
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
ebselen
1
durvalumab
1
disitamab vedotin
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Radiotherapy
×
30 days
×
Clear all
No trials found.